A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is a fearsome disease, with a mortality rate >95% that has remained unchanged for decades 1. GEMMs that faithfully recapitulate the histological, molecular, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results